Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19.
Blair PW, Brandsma J, Chenoweth J, Richard SA, Epsi NJ, Mehta R, Striegel D, Clemens EG, Alharthi S, Lindholm DA, Maves RC, Larson DT, Mende K, Colombo RE, Ganesan A, Lalani T, Colombo CJ, Malloy AA, Snow AL, Schully KL, Lanteri C, Simons MP, Dumler JS, Tribble D, Burgess T, Pollett S, Agan BK, Clark DV; EPICC COVID-19 Cohort Study Group.
Blair PW, et al. Among authors: ganesan a.
Sci Rep. 2022 Dec 28;12(1):22471. doi: 10.1038/s41598-022-26965-7.
Sci Rep. 2022.
PMID: 36577783
Free PMC article.